Precigen Inc PGEN

Healthcare Biotechnology

Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

NDAQ:PGEN - Post by User

Precigen Inc

Bullboard Posts

Post by MissingA9on Mar 22, 2016 7:28pm

121 Views

Post# 24690346

massive increase in brain damaged babies

2 billion for XON GM mosquitos to save 200 billion in long term care costs = good deal

https://www.theguardian.com/world/2016/mar/22/who-zika-virus-implicated-in-large-numbers-of-brain-damaged-babies

Bullboard Posts

GameSquare sells 25.5% interest in FaZe Media for $9.5 million